P1122: EFFICACY OF ALPELISIB IN PI3K-DRIVEN LANGERHANS CELL HISTIOCYTOSIS

• R. Mazor,
• B. Durham,
• O. Abdel-Wahab,
• E. Diamond,
• G. Itchaki,
• M. Ben-Sasson,
• O. Hershkovitz-Rokah,
• O. Shpilberg

Affiliations

R. Mazor

1 Clinic of Histiocytic Neoplasms, Institute of Hematology, Assuta Medical Center, Tel Aviv, Israel

B. Durham

2 Human Oncology and Pathogenesis Program

O. Abdel-Wahab

2 Human Oncology and Pathogenesis Program

E. Diamond

3 Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, United States of America

G. Itchaki

4 Department of Hematology, Rabin Medical Center, Petah Tikva

M. Ben-Sasson

5 The Institute for Pain Medicine, Rambam Medical Center

O. Hershkovitz-Rokah

1 Clinic of Histiocytic Neoplasms, Institute of Hematology, Assuta Medical Center, Tel Aviv, Israel

O. Shpilberg

1 Clinic of Histiocytic Neoplasms, Institute of Hematology, Assuta Medical Center, Tel Aviv, Israel